HE homepage

Investment

Solace Health, a company that connects patients with an "advocate" to help them navigate the U.S. healthcare system after a diagnosis, announced on Tuesday that it's earned $130 million in Series C funding, bringing its valuation to the coveted “unicorn status."

LLM

Medical AI is likely to pass along potentially dangerous misinformation when the distortion comes to the model from a normally trustworthy source using a convincingly authoritative voice. 

Rich Fabian, Medical Imaging Technology at AdvaMed Imaging chair of board, a medtech industry group made up of medical imaging companies to address higher level trends and public policy concerns, said tariffs are having a major impact for all vendors due to diverse supply chains that cannot be changed overnight. He said the U.S. tariffs and counter tariffs from, various countries will raise costs for U.S. health systems at a time where margins for them are already razor thin. #RSNA

AdvaMed, a medtech industry group made up of medical imaging companies, says tariffs are having a major impact for all vendors. 

Product Recall

The FDA has announced seven Class I recalls related to this issue. Customers are urged to destroy the devices immediately instead of returning them to the manufacturer. 

Robert Wachter MD

Someday the computerization of medicine will be recognized as the game-changing, paradigm-shifting, everything-upending “disruptive innovation” that so many healthcare watchers and stakeholders have been waiting for. “Today,” however, “it’s often just plain disruptive.”

insurance insurer payment claim denial reimbursement prior authorization

In a new poll, more insured adults listed receiving coverage approval for treatment and medications as the single largest burden they face when navigating the U.S. healthcare system than any other issue. KFF found that 47% experienced “denied, delayed or altered” patient care over the last two years. 

Around the web

Philips worked closely with Edwards Lifesciences to develop the new software.